Overview

Thyroid-stimulating hormone (TSH/thyrotropin) is a 92 kDa glycoprotein pituitary hormone, but specific peptide fragments derived from its sequences have been studied as research tools and potential therapeutics. TSH receptor (TSHR) activating peptides have been investigated in models of thyroid function restoration and ophthalmopathy associated with Graves' disease. Additionally, TSH peptide fragments have been explored in immunology as tools to understand TSHR autoimmunity. This entry focuses on the concept of TSH-derived peptide research rather than native TSH itself.

Mechanism of Action

Specific peptide sequences from the TSH alpha or beta subunits can interact with TSHR or with autoantibodies (TRAbs) that drive Graves' disease. TSHR is a Gs-coupled GPCR activating adenylyl cyclase and cAMP-mediated thyroid hormone synthesis and secretion. Research has focused on identifying TSHR agonist peptides that could restore thyroid function without the immunogenic burden of recombinant protein TSH, and on TSHR antagonist peptides for Graves' disease management.

Potential Benefits

  • Research tools for understanding TSHR autoimmunity in Graves' disease
  • Potential TSHR-modulating peptide drugs avoiding full protein administration
  • Insights into TSH receptor structure-function relationships

Research Dosage Notes

The following reflects doses used in published research studies. This is not medical advice.

Research use only.

Amino Acid Sequence

Various fragments of TSH alpha/beta chains under study

Side Effects & Safety

  • Research context; systemic effects not established for fragments

Synergistic Compounds

The following compounds have been studied alongside Thyroid-Stimulating Hormone (TSH) Peptides for potential complementary or synergistic effects:

Recombinant TSH (Thyrogen)Thyroxine

Learn More

References & Further Reading

  • [object Object]

More Peptides in This Category